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Primary tumors within the abdomen frequently spread to the mesentery and omentum, but these deposits may not 
cause symptoms until they grow large enough to displace organs or cause intestinal obstruction. We present an 
uncommon case of occult ovarian serous adenocarcinoma presenting as a solitary metastatic omental mass. A 72-year-
old female patient found a hard, mobile subcutaneous mass located at the umbilical area. This mass gradually became 
larger, but there were no symptoms in the gastrointestinal tract. Abdominal ultrasonography showed a homogenous, 
hypoechoic lesion. A preoperative diagnosis of a huge intra-abdominal lipoma was made, and surgical intervention was 
carried out. Intraoperatively, we found a tumor mass located in the greater omentum without ascites. The surgical 
procedure consisted of a complete resection of the omental mass. Frozen section analysis by the pathologist revealed 
a metastatic serous adenocarcinoma. Intra-abdominal organs including the gastrointestinal tract, ovaries, uterus and 
pancreas were examined carefully; however, no abnormal lesions were identified either grossly or palpably. Two 
months after the operation, a computed tomographic scan of the abdomen was performed, and a cystic mass lesion with 
a 0.9-cm lobulated margin was confirmed in the posterior wall of the right ovary. The patient was then referred to a 
gynecologist for further survey and underwent another operation. Finally, a pathologic report of the right ovary showed 
that the primary lesion of this metastatic omental cancer originated from right ovarian cancer. This case demon-
strates the possibility of development of a metastatic omental mass from an occult ovarian serous adenocarcinoma.
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Introduction
Solitary solid tumors in the mesentery and omen-
tum are uncommon lesions. Primary and secondary 
neoplasms of the peritoneum may often present as 
multiple nodules, masses or diffuse involvement of 
the peritoneum. Most of the tumor presents as a lat-
erally mobile abdominal swelling with gradual onset. 
A peritoneal mass can be benign or malignant (primary 
or metastatic).1 Primary tumors within the abdomen 
frequently spread to the mesentery and omentum, 
but these deposits may not cause symptoms until they 
grow large enough to displace organs or cause intes-
tinal obstruction.2 The most common malignant tumor 
involving the mesentery is metastatic carcinoma. 
Such metastases usually arise intra-abdominally from 
the stomach, colon and ovary, and less often from 
the pancreas, biliary tract, kidney and uterus.3
We report a case with uncommon clinical presen-
tations. The patient found an abdominal mass and 
did not have any physical discomfort or symptoms/
signs 3 months before the first surgical intervention. 
Subsequently, metastatic omental carcinoma was di-
agnosed, and it was a successful treatment through-
out the 12-month follow-up.
Materials and Methods
Materials
A 72-year-old female patient visited the outpatient 
department of Kaohsiung Medical University Hospital 
because of gradual onset of an abdominal mass 
over 3 months. She had previously been healthy ex-
cept for a past history of diabetes mellitus and hy-
pertension, and had been taking medicine for many 
years. Clinically, except for the abdominal mass, 
she had no complaints of abdominal symptoms. On 
general physical examination, her abdomen was 
normal except for a palpable, mobile subcutane-
ous mass. Mild tenderness was found over the middle 
quadrant of the abdominal wall. Abdominal ultra-
sonography showed an intra-abdominal mass. The 
mass was homogenous and hypoechoic, and the size 
was approximately 7 × 8 cm. The tentative diagnosis 
for this patient was a huge intra-abdominal lipoma. 
In addition, the laboratory data did not reveal any 
abnormalities. We performed surgical intervention 
for the patient on the basis of the clinical symptoms 
and the patient’s wishes.
Methods
Unfortunately, during laparotomy, we found a huge 
mass located in the greater omentum, and a bi-
opsy specimen was obtained for frozen pathology. 
We dissected the omental mass very carefully and 
complete excision was performed. The biopsy spec-
imen report demonstrated that it was a metastatic 
serous adenocarcinoma (Figure 1). Notably, there 
was no ascites in the abdominal cavity, and the pari-
etal or visceral peritoneum was grossly or palpably 
normal. Moreover, we examined the intra-abdominal 
organs including the gastrointestinal tract, colon, 
ovaries, uterus and pancreas cautiously but found 
no abnormal lesions.
For further validation of the resected tumor, 
we carried out immunohistochemical staining with 
various antibodies, which included cytokeratin 7 
(CK-7), cytokeratin 20 (CK-20), and epithelial mem-
brane antigen (EMA). We found that the results were 
positive for CK-7 (Figure 2A), negative for CK-20 
(Figure 2B), and positive for EMA (Figure 2C). This 
metastatic omental cancer most likely originated 
from the ovary. We also detected serum tumor mark-
ers including carcinoembryonic antigen and carbohy-
drate antigen 125. Serum carcinoembryonic antigen 
level was 1.69 ng/mL (normal range, < 5 ng/mL) and 
carbohydrate antigen 125 was elevated to 185.7 U/
mL (normal range, 3.6−54 U/mL).
Results
Abdominal computed tomography (CT) was carried 
out for the identification of the primary lesion 2 
months after the first operation despite there 
being no prominent gross lesion during the operation, 
and it confirmed a lobulated margin around a 0.9-cm 
cystic lesion in the posterior wall of the right ovary 
(Figure 3). Therefore, the patient was referred to 
the gynecologist for further survey and surgical inter-
vention. After abdominal total hysterotomy, bilateral 
salpingo-oophorectomy and bilateral pelvic lymph 
Figure 1 Histopathology of the omental mass (hematox-
ylin and eosin, 100×). The metastatic malignant glandular 
structure is indicated by the arrows.
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Figure 2 (A) Immunohistochemical stain of cytokeratin 
7 shows a positive reaction (arrow, 100×). (B) Immuno-
histochemical stain of cytokeratin 20 shows a negative 
reaction (arrow, 100×). (C) Immunohistochemical stain of 
epithelial membrane antigen shows a positive reaction 
(arrow, 100×).
Figure 3 Abdominal computed tomography scan of a 
cystic mass lesion approximately 2.7 × 2.4 × 2.8 cm with a 
lobulated margin in the right ovary (arrow).
Figure 4 Histopathology of the right ovarian tumor 
(hematoxylin and eosin, 100×). Malignant serous adeno-
carcinoma shows a papillary and glandular or cribriform 
pattern (arrows).
node sampling, the pathologic report confirmed se-
rous adenocarcinoma of the right ovary (Figure 4). 
The recovery course was smooth, and the patient was 
discharged uneventfully. The patient was followed 
up for 12 months, and she was free of symptoms.
Discussion
The greater omentum is a prominent peritoneal fold 
formed by continuation of the anterior and posterior 
visceral peritoneum of the stomach. Solitary solid 
tumors originating in the intra-abdominal mesentery 
and in the omentum are rare lesions associated with 
an insidious onset and with a laterally ballotable mass 
frequently representing the only clinical sign.1,4 
The most common cause of the omental pathologic 
condition is metastasis from an abdominal or pel-
vic malignant neoplasm. In men, the most common 
types of cancer leading to omental metastases are 
neoplasms of the gastrointestinal tract, including 
the stomach, colon, and pancreas; in women, how-
ever, the most common cause of omental metasta-
ses is ovarian carcinoma.5,6 Some times, the greater 
omentum can be involved in inflammatory processes, 
such as bacterial or tuberculous peritonitis.7 Rarely, 
primary neoplasms can arise within the greater 
omentum.8 Gershenson and Silva9 demonstrated 
that the omentum is one of the most common sites 
of peritoneal implants of serous ovarian tumors.
Intra-peritoneal spread of neoplasms can occur 
in four different ways: direct spread through me-
senteric and ligamentous attachments, intraperi-
toneal seeding, lymphatic extension, and embolic 
hematogenous dissemination.2 In cases of omental 
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mass, histologic diagnosis should be mandatory to 
distinguish between these low-aggressive lesions and 
others such as sarcoma and intraperitoneal adeno-
carcinoma. CT scans are very useful in the radiologic 
diagnosis of omental disease, and can provide ex-
cellent demonstration of extra-luminal abdominal 
masses located in the peritoneum, omentum and 
mesentery.10 Additionally, the presence of ascetic 
fluid is an important aid in the detection of these 
metastases.11 Recently, immunohistochemical anal-
ysis has been used to predict and detect the origin 
of tumors.12,13 Immunohistochemical studies on met-
astatic carcinoma of an unknown primary site may 
be helpful in the identification of tumor origin, es-
pecially if the metastases are poorly differentiated 
by light microscopy.14 Immunoperoxidase staining 
on formalin-fixed paraffinized tissue facilitates its 
diagnostic application in the detection of the tumor 
origin. Several cell components can be identified by 
a series of monoclonal or polyclonal immunoper-
oxidase antibodies including enzymes, structural tis-
sue components, hormonal receptors, hormones, and 
oncofetal antigens.15 The development of monoclonal 
antibodies against various cytokeratin polypeptides 
has opened up new avenues for the investigation of 
normal and cancerous epithelial cells. CK-20 appears 
to be very useful in diagnosing gastrointestinal ad-
enocarcinoma, while CK-7 is more common in res-
piratory or gynecologic malignancies. Overall, the 
CK-7 positive (+)/CK-20 negative (−) phenotype fa-
vors lung, breast and primary ovarian cancers, the 
CK-7 + /CK-20 + phenotype favors urothelial/transi-
tional cell carcinoma, the CK-7−/CK-20+ phenotype 
favors colorectal and gastric carcinomas, and the 
CK-7−/CK-20− phenotype favors prostatic, renal and 
liver adenocarcinomas.16,17 Metastatic carcinoma 
cells in serous effusions are usually stained strongly 
with EMA. In 2009, Matsuura et al18 reported an ex-
tremely rare case of serous adenocarcinoma with a 
cystic tumor that was categorized as extraovarian 
peritoneal serous papillary carcinoma without other 
clinical findings. Our immunohistochemical studies 
and the study by Matsuura et al18 suggest that the 
primitive site of these cystic tumors should be of 
ovarian origin. Our patient was finally diagnosed with 
a metastatic omental tumor, which was caused by 
ovarian carcinoma as shown by CT and immunohis-
tochemistry. Although the omentum is one of the 
most common metastatic sites of serous ovarian tu-
mors, there are four points worth noting in this case: 
(1) this patient had no clinical symptoms or signs 
except for a gradually growing, palpable abdominal 
mass; (2) there was no ascitic fluid or peritoneal 
seeding masses found intraoperatively; (3) we did 
not identify the primary lesion visibly; and (4) a small 
lobulated lesion (diameter, < 1 cm) of the ovary can 
result in a huge, metastatic omental mass.
This is a rare case with regard to the clinical and 
radiologic findings. Ovarian cancer is a very impor-
tant primary lesion of metastatic omental tumors in 
women, even if the ovarian lesion is relatively small, 
and it could spread to the omentum. Although such 
cases are rarely encountered, surgeons should be 
aware of this possibility to avoid misdiagnosis, which 
could lead to progression of this disease.
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